Literature DB >> 17955033

Spinal cord arteriovenous malformation presenting as chest pain in a child.

C-C Chen1, C-M Wang, N-K Chu, K P-H Wu, S F-T Tang, A M-K Wong.   

Abstract

STUDY
DESIGN: A case report of spinal arteriovenous malformation presented as chest pain in a child.
OBJECTIVES: To illustrate the atypical clinical presentation as right chest pain in a child with spinal cord arteriovenous malformation.
SETTING: Chang Gung Memorial Hospital and Chang Gung University, Taiwan. CASE REPORT: An 8-year-old boy was diagnosed with spinal cord arteriovenous malformation after paraplegia. However, early diagnosis was delayed for the atypical initial clinical presentation as chest pain. After surgery and rehabilitation for 6 months, the patient could walk without assistance.
CONCLUSIONS: Correct diagnosis of spinal cord arteriovenous malformations is sometimes difficult in children with atypical presentations. Early diagnosis relies on detailed examination and high index of suspicion.

Entities:  

Mesh:

Year:  2007        PMID: 17955033     DOI: 10.1038/sj.sc.3102133

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  3 in total

1.  Ruptured spinal arteriovenous malformation: Presenting as stunned myocardium and neurogenic shock.

Authors:  Tasneem H Mehesry; Nissar Shaikh; Mohammad F Malmstrom; Marco A E Marcus; Adnan Khan
Journal:  Surg Neurol Int       Date:  2015-09-28

2.  Spontaneous epidural spinal haematoma in children caused by vascular malformations.

Authors:  Ramanan Sivakumaran; Andrew King; Istvan Bodi; Christopher L Chandler; Daniel C Walsh
Journal:  Eur Spine J       Date:  2014-10-10       Impact factor: 3.134

Review 3.  Intramedullary spinal cord cavernous malformations presenting with unexplained chest pain: case report and review of the literature.

Authors:  Salvatore Savasta; Mattia Algeri; Elisabetta De Sando; Alessandro Lozza; Georgia Mussati; Davide Locatelli; Gian Luigi Marseglia
Journal:  Childs Nerv Syst       Date:  2012-10-21       Impact factor: 1.475

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.